202 related articles for article (PubMed ID: 35900315)
1. XIST as a valuable biomarker for prognosis and clinical parameters in diverse tumors: a comprehensive meta- and bioinformatics analysis.
Zhang MJ; Yan Z; Qin J; Luo TH; Yang B
Neoplasma; 2022 Sep; 69(5):1217-1227. PubMed ID: 35900315
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA X-inactive specific transcript as a prognostic factor in cancer patients: A meta-analysis based on retrospective studies.
Chen J; Yang X; Gong D; Cui Y; Hu J; Li H; Liu P; Li C; Cheng X; Liu L; Chen H; Zu X
Medicine (Baltimore); 2019 Jan; 98(3):e14095. PubMed ID: 30653128
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA XIST predicts worse prognosis in digestive system tumors: a systemic review and meta-analysis.
Liu X; Ming X; Jing W; Luo P; Li N; Zhu M; Yu M; Liang C; Tu J
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29752340
[TBL] [Abstract][Full Text] [Related]
4. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.
Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W
BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and clinicopathological value of long noncoding RNA XIST in cancer.
Zhu J; Kong F; Xing L; Jin Z; Li Z
Clin Chim Acta; 2018 Apr; 479():43-47. PubMed ID: 29307668
[TBL] [Abstract][Full Text] [Related]
6. The clinical prognostic value of lncRNA FOXP4-AS1 in cancer patients: A meta-analysis and bioinformatics analysis based on TCGA datasets.
Shu Q; Liu X; Yang J; Mou T; Xie F
Medicine (Baltimore); 2022 Oct; 101(42):e31439. PubMed ID: 36281152
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA XIST expression as a prognostic factor in human cancers: A meta-analysis.
Yin S; Dou J; Yang G; Chen F
Int J Biol Markers; 2019 Dec; 34(4):327-333. PubMed ID: 31566056
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of long noncoding RNA XIST is associated with poor prognosis in human cancers.
Liu JL; Zhang WQ; Zhao M; Huang MY
J Cell Physiol; 2019 May; 234(5):6594-6600. PubMed ID: 30341910
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of long non-coding RNA five prime to XIST in various cancers.
Zhou J; Chen J; Chen Z; Wu G; Zhou Z; Wu T; Wang W; Luo Y; Liu T
BMC Cancer; 2022 Jan; 22(1):61. PubMed ID: 35027040
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Liu X; Huang G; Zhang J; Zhang L; Liang Z
PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
[TBL] [Abstract][Full Text] [Related]
11. Long non coding RNA XIST as a prognostic cancer marker - A meta-analysis.
Zhou Q; Hu W; Zhu W; Zhang F; Lin-Lin L; Liu C; Songyang YY; Sun CC; Li D
Clin Chim Acta; 2018 Jul; 482():1-7. PubMed ID: 29577911
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
Zhang S; Qiu D; Xie X; Shen Y
BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
[TBL] [Abstract][Full Text] [Related]
14. LINC00511 as a prognostic biomarker for human cancers: a systematic review and meta-analysis.
Agbana YL; Abi ME; Ni Y; Xiong G; Chen J; Yun F; Yi Z; Zhang Q; Yang Z; Kuang Y; Zhu Y
BMC Cancer; 2020 Jul; 20(1):682. PubMed ID: 32698787
[TBL] [Abstract][Full Text] [Related]
15. A study of the prognostic value of long non-coding RNA CASC15 in human solid tumors utilizing The Cancer Genome Atlas (TCGA) datasets and a meta-analysis.
Chen W; Qian W; Nie J; Dai M
Clin Exp Med; 2023 Feb; 23(1):65-78. PubMed ID: 35103883
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA XIST as a potential prognostic biomarker in human cancers: a meta-analysis.
Hu S; Chang J; Li Y; Wang W; Guo M; Zou EC; Wang Y; Yang Y
Oncotarget; 2018 Mar; 9(17):13911-13919. PubMed ID: 29568404
[TBL] [Abstract][Full Text] [Related]
17. LncRNA NR2F1-AS1 as a potential biomarker for prognosis in cancer patients: meta and bioinformatics analysis.
Tang L; Liu QM; Zhang S; Zhou J
Expert Rev Mol Diagn; 2023; 23(12):1263-1272. PubMed ID: 37902251
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of long non-coding RNA XIST expression in patients with solid tumors: a meta-analysis.
Mao H; Wang K; Feng Y; Zhang J; Pan L; Zhan Y; Sheng H; Luo G
Cancer Cell Int; 2018; 18():34. PubMed ID: 29556138
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
